​

OmniAb (OABI) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

OABI Stock Rating

OmniAb stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

OABI Price Target Upside V Benchmarks

TypeNameUpside
StockOmniAb-
SectorHealthcare Stocks 25.19%
IndustryBiotech Stocks 61.26%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$3.67$3.67$3.67
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 2526---8
Jan, 2526---8
Dec, 2426---8
Nov, 2426---8
Oct, 2426---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 20, 2022Piper SandlerOverweightinitialise
Dec 16, 2022Credit SuisseOutperforminitialise

Financial Forecast

EPS Forecast

Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.26$-0.51-----
Avg Forecast$-0.37$-0.49$-0.55$-0.37$-0.23$-0.12$-0.03
High Forecast$-0.19$-0.48$-0.50$-0.22$-0.04$-0.08$-0.01
Low Forecast$-0.56$-0.53$-0.60$-0.51$-0.37$-0.19$-0.05
Surprise %-29.73%4.08%-----

Revenue Forecast

$20M $40M $60M $80M $100M $120M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$59.08M$34.16M-----
Avg Forecast$51.73M$37.85M$25.75M$45.98M$62.56M$68.48M$80.50M
High Forecast$72.08M$40.85M$28.13M$66.72M$63.73M$68.56M$118.77M
Low Forecast$32.51M$35.11M$22.19M$25.92M$61.39M$68.41M$46.13M
Surprise %14.21%-9.73%-----

Net Income Forecast

$-65M $-52M $-39M $-26M $-13M $0 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-22.33M$-50.62M-----
Avg Forecast$-37.21M$-50.62M$-55.15M$-48.16M$-36.97M$-13.57M$-2.99M
High Forecast$-19.24M$-47.36M$-50.22M$-21.65M$-4.15M$-8.32M$-1.33M
Low Forecast$-56.26M$-52.93M$-60.08M$-50.51M$-37.32M$-18.82M$-4.84M
Surprise %-39.99%------

OABI Forecast FAQ

Is OmniAb stock a buy?

OmniAb stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that OmniAb is a favorable investment for most analysts.

What is OmniAb's price target?

OmniAb's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $3.67.

How does OmniAb stock forecast compare to its benchmarks?

OmniAb's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (25.19%) and underperforming the biotech stocks industry (61.26%).

What is the breakdown of analyst ratings for OmniAb over the past three months?

  • February 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is OmniAb’s EPS forecast?

OmniAb's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.55, marking a 7.84% increase from the reported $-0.51 in 2023. Estimates for the following years are $-0.37 in 2025, $-0.23 in 2026, $-0.12 in 2027, and $-0.03 in 2028.

What is OmniAb’s revenue forecast?

OmniAb's average annual revenue forecast for its fiscal year ending in December 2024 is $25.75M, reflecting a -24.64% decrease from the reported $34.16M in 2023. The forecast for 2025 is $45.98M, followed by $62.56M for 2026, $68.48M for 2027, and $80.5M for 2028.

What is OmniAb’s net income forecast?

OmniAb's net income forecast for the fiscal year ending in December 2024 stands at $-55.15M, representing an 8.95% increase from the reported $-50.619M in 2023. Projections indicate $-48.164M in 2025, $-36.97M in 2026, $-13.567M in 2027, and $-2.99M in 2028.